KUALA LUMPUR, June 19 (Bernama) -- Medidata, a Dassault Systèmes brand and clinical trial solutions to the life sciences industry provider, has launched the Medidata Clinical Data Studio, a unified experience that unlocks the true power of clinical research data.
In a statement, Medidata said this groundbreaking technology will give stakeholders greater control over the quality of data and the ability to deliver safer trials to patients faster.
“Clinical Data Studio unlocks the broad ecosystem of clinical data. Powered by embedded AI, we are democratising access to data and revealing the signals, risks, and insights that matter most.
“Together this accelerates trial execution and creates rich data for new discoveries,” said Medidata chief technology officer, Tom Doyle.
Built on the Medidata Platform, Clinical Data Studio integrates data from both Medidata and non-Medidata sources, accelerating decision-making across the full clinical trial process and delivering holistic data and risk strategies that connect patients, sites, and sponsors.
Through artificial intelligence (AI), study teams can more effectively identify potential data issues and safety signals, resulting in a more accurate understanding of the patient.
This reduces the challenges posed by siloed data systems and enables action data review and reconciliation up to 80 per cent faster.
Clinical Data Studio offers a comprehensive workspace for data integration, transformation, and management.
It includes AI-assisted data reconciliation and anomaly detection, self-serve data listings, robust risk-based quality management, and tools to implement a holistic data and risk strategy supported by workflows and visualisations.
-- BERNAMA
No comments:
Post a Comment